{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,9]],"date-time":"2026-05-09T02:15:05Z","timestamp":1778292905176,"version":"3.51.4"},"reference-count":44,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,8,29]],"date-time":"2020-08-29T00:00:00Z","timestamp":1598659200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,8,29]],"date-time":"2020-08-29T00:00:00Z","timestamp":1598659200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100001871","name":"Funda\u00e7\u00e3o para a Ci\u00eancia e a Tecnologia","doi-asserted-by":"publisher","award":["SFRH\/BD\/123678\/2016"],"award-info":[{"award-number":["SFRH\/BD\/123678\/2016"]}],"id":[{"id":"10.13039\/501100001871","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int J Clin Pharm"],"published-print":{"date-parts":[[2021,2]]},"DOI":"10.1007\/s11096-020-01117-x","type":"journal-article","created":{"date-parts":[[2020,8,29]],"date-time":"2020-08-29T08:03:41Z","timestamp":1598688221000},"page":"128-136","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":17,"title":["Size of the associations between anticholinergic burden tool scores and adverse outcomes in older patients"],"prefix":"10.1007","volume":"43","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8582-7853","authenticated-orcid":false,"given":"Marta","family":"Lavrador","sequence":"first","affiliation":[]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6973-0544","authenticated-orcid":false,"given":"Ana C.","family":"Cabral","sequence":"additional","affiliation":[]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0127-4575","authenticated-orcid":false,"given":"Isabel V.","family":"Figueiredo","sequence":"additional","affiliation":[]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2793-2129","authenticated-orcid":false,"given":"Manuel T.","family":"Ver\u00edssimo","sequence":"additional","affiliation":[]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6533-9932","authenticated-orcid":false,"given":"M. Margarida","family":"Castel-Branco","sequence":"additional","affiliation":[]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8529-9595","authenticated-orcid":false,"given":"Fernando","family":"Fernandez-Llimos","sequence":"additional","affiliation":[]}],"member":"297","published-online":{"date-parts":[[2020,8,29]]},"reference":[{"key":"1117_CR1","doi-asserted-by":"crossref","first-page":"2120","DOI":"10.1111\/jgs.13647","volume":"63","author":"JG Naples","year":"2015","unstructured":"Naples JG, Marcum ZA, Perera S, Gray SL, Newman AB, Simonsick EM, et al. Concordance between anticholinergic burden scales. J Am Geriatr Soc. 2015;63:2120\u20134.","journal-title":"J Am Geriatr Soc"},{"key":"1117_CR2","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1517\/14740338.2016.1165664","volume":"15","author":"PS Nishtala","year":"2016","unstructured":"Nishtala PS, Salahudeen MS, Hilmer SN. Anticholinergics: theoretical and clinical overview. Expert Opin Drug Saf. 2016;15:753\u201368.","journal-title":"Expert Opin Drug Saf"},{"key":"1117_CR3","doi-asserted-by":"crossref","first-page":"1485","DOI":"10.1007\/s00228-013-1499-3","volume":"69","author":"CE Duran","year":"2013","unstructured":"Duran CE, Azermai M, Vander Stichele RH. Systematic review of anticholinergic risk scales in older adults. Eur J Clin Pharmacol. 2013;69:1485\u201396.","journal-title":"Eur J Clin Pharmacol"},{"key":"1117_CR4","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1186\/s12877-015-0029-9","volume":"15","author":"MS Salahudeen","year":"2015","unstructured":"Salahudeen MS, Duffull SB, Nishtala PS. Anticholinergic burden quantified by anticholinergic risk scales and adverse outcomes in older people: a systematic review. BMC Geriatr. 2015;15:31.","journal-title":"BMC Geriatr"},{"key":"1117_CR5","doi-asserted-by":"crossref","first-page":"1299","DOI":"10.1007\/s00228-015-1932-x","volume":"71","author":"T Mayer","year":"2015","unstructured":"Mayer T, Haefeli WE, Seidling HM. Different methods, different results\u2014How do available methods link a patient\u2019s anticholinergic load with adverse outcomes? Eur J Clin Pharmacol. 2015;71:1299\u2013314.","journal-title":"Eur J Clin Pharmacol"},{"key":"1117_CR6","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.archger.2015.10.002","volume":"62","author":"AM Villalba-Moreno","year":"2016","unstructured":"Villalba-Moreno AM, Alfaro-Lara ER, Perez-Guerrero MC, Nieto-Martin MD, Santos-Ramos B. Systematic review on the use of anticholinergic scales in poly pathological patients. Arch Gerontol Geriatr. 2016;62:1\u20138.","journal-title":"Arch Gerontol Geriatr"},{"key":"1117_CR7","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1111\/bcpt.12140","volume":"114","author":"H Kersten","year":"2014","unstructured":"Kersten H, Wyller TB. Anticholinergic drug burden in older people\u2019s brain\u2014How well is it measured? Basic Clin Pharmacol Toxicol. 2014;114:151\u20139.","journal-title":"Basic Clin Pharmacol Toxicol"},{"key":"1117_CR8","doi-asserted-by":"crossref","first-page":"1592","DOI":"10.1592\/phco.2005.25.11.1592","volume":"25","author":"KM Rudd","year":"2005","unstructured":"Rudd KM, Raehl CL, Bond CA, Abbruscato TJ, Stenhouse AC. Methods for assessing drug-related anticholinergic activity. Pharmacotherapy. 2005;25:1592\u2013601.","journal-title":"Pharmacotherapy"},{"key":"1117_CR9","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1007\/s40266-015-0310-9","volume":"32","author":"K Cardwell","year":"2015","unstructured":"Cardwell K, Hughes CM, Ryan C. The association between anticholinergic medication burden and health related outcomes in the \u2018oldest old\u2019: a systematic review of the literature. Drugs Aging. 2015;32:835\u201348.","journal-title":"Drugs Aging"},{"key":"1117_CR10","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1007\/s40266-018-0549-z","volume":"35","author":"TJ Welsh","year":"2018","unstructured":"Welsh TJ, van der Wardt V, Ojo G, Gordon AL, Gladman JRF. Anticholinergic drug burden tools\/scales and adverse outcomes in different clinical settings: a systematic review of reviews. Drugs Aging. 2018;35:523\u201338.","journal-title":"Drugs Aging"},{"key":"1117_CR11","doi-asserted-by":"crossref","first-page":"279","DOI":"10.4300\/JGME-D-12-00156.1","volume":"4","author":"GM Sullivan","year":"2012","unstructured":"Sullivan GM, Feinn R. Using effect size-or why the P value is not enough. J Grad Med Educ. 2012;4:279\u201382.","journal-title":"J Grad Med Educ."},{"key":"1117_CR12","doi-asserted-by":"crossref","first-page":"384","DOI":"10.20344\/amp.12082","volume":"33","author":"J Oliveira","year":"2020","unstructured":"Oliveira J, Cabral AC, Lavrador M, Costa FA, Almeida FF, Macedo A, et al. Contribution of different patient information sources to create the best possible medication history. Acta Med Port. 2020;33:384\u20139.","journal-title":"Acta Med Port"},{"key":"1117_CR13","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1001\/archinternmed.2007.106","volume":"168","author":"JL Rudolph","year":"2008","unstructured":"Rudolph JL, Salow MJ, Angelini MC, McGlinchey RE. The anticholinergic risk scale and anticholinergic adverse effects in older persons. Arch Intern Med. 2008;168:508\u201313.","journal-title":"Arch Intern Med"},{"key":"1117_CR14","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.1177\/0091270006292126","volume":"46","author":"RM Carnahan","year":"2006","unstructured":"Carnahan RM, Lund BC, Perry PJ, Pollock BG, Culp KR. The Anticholinergic Drug Scale as a measure of drug-related anticholinergic burden: associations with serum anticholinergic activity. J Clin Pharmacol. 2006;46:1481\u20136.","journal-title":"J Clin Pharmacol"},{"key":"1117_CR15","first-page":"S142","volume":"61","author":"NL Campbell","year":"2013","unstructured":"Campbell NL, Maidment I, Fox C, Khan B, Boustani M. The 2012 Update to the Anticholinergic Cognitive Burden Scale. J Am Geriatr Soc. 2013;61:S142\u20133.","journal-title":"J Am Geriatr Soc"},{"key":"1117_CR16","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1001\/archinte.167.8.781","volume":"167","author":"SN Hilmer","year":"2007","unstructured":"Hilmer SN, Mager DE, Simonsick EM, Cao Y, Ling SM, Windham BG, et al. A drug burden index to define the functional burden of medications in older people. Arch Intern Med. 2007;167:781\u20137.","journal-title":"Arch Intern Med"},{"issue":"1142\u20139","key":"1117_CR17","first-page":"e1","volume":"122","author":"SN Hilmer","year":"2009","unstructured":"Hilmer SN, Mager DE, Simonsick EM, Ling SM, Windham BG, Harris TB, et al. Drug burden index score and functional decline in older people. Am J Med. 2009;122(1142\u20139):e1\u20132.","journal-title":"Am J Med"},{"key":"1117_CR18","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1111\/bcp.13479","volume":"84","author":"J O\u2019Connell","year":"2018","unstructured":"O\u2019Connell J, Burke E, Mulryan N, O\u2019Dwyer C, Donegan C, McCallion P, et al. Drug burden index to define the burden of medicines in older adults with intellectual disabilities: an observational cross-sectional study. Br J Clin Pharmacol. 2018;84:553\u201367.","journal-title":"Br J Clin Pharmacol"},{"key":"1117_CR19","doi-asserted-by":"crossref","first-page":"458","DOI":"10.3109\/07853890.2011.573499","volume":"44","author":"D Gnjidic","year":"2012","unstructured":"Gnjidic D, Bell JS, Hilmer SN, Lonnroos E, Sulkava R, Hartikainen S. Drug Burden Index associated with function in community-dwelling older people in Finland: a cross-sectional study. Ann Med. 2012;44:458\u201367.","journal-title":"Ann Med"},{"key":"1117_CR20","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1093\/gerona\/gls176","volume":"68","author":"H Kersten","year":"2013","unstructured":"Kersten H, Molden E, Tolo IK, Skovlund E, Engedal K, Wyller TB. Cognitive effects of reducing anticholinergic drug burden in a frail elderly population: a randomized controlled trial. J Gerontol A Biol Sci Med Sci. 2013;68:271\u20138.","journal-title":"J Gerontol A Biol Sci Med Sci"},{"key":"1117_CR21","doi-asserted-by":"crossref","first-page":"1801","DOI":"10.1097\/00005537-200410000-00023","volume":"114","author":"PH Jongerius","year":"2004","unstructured":"Jongerius PH, van Limbeek J, Rotteveel JJ. Assessment of salivary flow rate: biologic variation and measure error. Laryngoscope. 2004;114:1801\u20134.","journal-title":"Laryngoscope"},{"key":"1117_CR22","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1186\/1472-6831-12-29","volume":"12","author":"CD Lofgren","year":"2012","unstructured":"Lofgren CD, Wickstrom C, Sonesson M, Lagunas PT, Christersson C. A systematic review of methods to diagnose oral dryness and salivary gland function. BMC Oral Health. 2012;12:29.","journal-title":"BMC Oral Health."},{"key":"1117_CR23","unstructured":"Schirmer Test. Available at: https:\/\/www.sciencedirect.com\/topics\/medicine-and-dentistry\/schirmer-test. Accessed 2019-07-18.."},{"key":"1117_CR24","first-page":"61","volume":"14","author":"FI Mahoney","year":"1965","unstructured":"Mahoney FI, Barthel DW. Functional evaluation: the Barthel Index. Md State Med J. 1965;14:61\u20135.","journal-title":"Md State Med J"},{"key":"1117_CR25","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1007\/s40266-012-0044-x","volume":"30","author":"L Pasina","year":"2013","unstructured":"Pasina L, Djade CD, Lucca U, Nobili A, Tettamanti M, Franchi C, et al. Association of anticholinergic burden with cognitive and functional status in a cohort of hospitalized elderly: comparison of the anticholinergic cognitive burden scale and anticholinergic risk scale: results from the REPOSI study. Drugs Aging. 2013;30:103\u201312.","journal-title":"Drugs Aging"},{"key":"1117_CR26","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/0022-3956(75)90026-6","volume":"12","author":"MF Folstein","year":"1975","unstructured":"Folstein MF, Folstein SE, McHugh PR. Mini-mental state A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res. 1975;12:189\u201398.","journal-title":"J Psychiatr Res."},{"key":"1117_CR27","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1111\/j.1365-2125.2009.03411.x","volume":"68","author":"D Gnjidic","year":"2009","unstructured":"Gnjidic D, Cumming RG, Le Couteur DG, Handelsman DJ, Naganathan V, Abernethy DR, et al. Drug Burden Index and physical function in older Australian men. Br J Clin Pharmacol. 2009;68:97\u2013105.","journal-title":"Br J Clin Pharmacol"},{"key":"1117_CR28","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1037\/a0024338","volume":"141","author":"CO Fritz","year":"2012","unstructured":"Fritz CO, Morris PE, Richler JJ. Effect size estimates: current use, calculations, and interpretation. J Exp Psychol Gen. 2012;141:2\u201318.","journal-title":"J Exp Psychol Gen"},{"key":"1117_CR29","volume-title":"Statistical power analysis for the behavioral sciences","author":"J Cohen","year":"1988","unstructured":"Cohen J. Statistical power analysis for the behavioral sciences. 2nd ed. Mahwah: Lawrence Erlbaum; 1988.","edition":"2"},{"key":"1117_CR30","first-page":"627","volume":"4","author":"K Hajian-Tilaki","year":"2013","unstructured":"Hajian-Tilaki K. Receiver operating characteristic (ROC) curve analysis for medical diagnostic test evaluation. Caspian J Intern Med. 2013;4:627\u201335.","journal-title":"Caspian J Intern Med"},{"key":"1117_CR31","unstructured":"The Area Under a ROC Curve. Available at: http:\/\/gim.unmc.edu\/dxtests\/roc3.htm. Accessed 18 July 2019."},{"key":"1117_CR32","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1016\/j.clindermatol.2017.06.010","volume":"35","author":"JW Millsop","year":"2017","unstructured":"Millsop JW, Wang EA, Fazel N. Etiology, evaluation, and management of xerostomia. Clin Dermatol. 2017;35:468\u201376.","journal-title":"Clin Dermatol"},{"key":"1117_CR33","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1016\/j.sapharm.2019.05.023","volume":"16","author":"JB Schreiber","year":"2019","unstructured":"Schreiber JB. New paradigms for considering statistical significance: a way forward for health services research journals, their authors, and their readership. Res Soc Adm Pharm. 2019;16:591\u20134.","journal-title":"Res Soc Adm Pharm."},{"key":"1117_CR34","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1080\/00031305.2016.1154108","volume":"70","author":"RL Wasserstein","year":"2016","unstructured":"Wasserstein RL, Lazar NA. The ASA statement on p-values: context, process, and purpose. The American Statistician. 2016;70:129\u201333.","journal-title":"The American Statistician."},{"key":"1117_CR35","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1111\/j.1365-2125.2012.04411.x","volume":"75","author":"H Kersten","year":"2013","unstructured":"Kersten H, Molden E, Willumsen T, Engedal K, Bruun WT. Higher anticholinergic drug scale (ADS) scores are associated with peripheral but not cognitive markers of cholinergic blockade. cross sectional data from 21 Norwegian nursing homes. Br J Clin Pharmacol. 2013;75:842\u20139.","journal-title":"Br J Clin Pharmacol"},{"key":"1117_CR36","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1007\/s00228-016-2162-6","volume":"73","author":"H Wouters","year":"2017","unstructured":"Wouters H, van der Meer H, Taxis K. Quantification of anticholinergic and sedative drug load with the Drug Burden Index: a review of outcomes and methodological quality of studies. Eur J Clin Pharmacol. 2017;73:257\u201366.","journal-title":"Eur J Clin Pharmacol"},{"key":"1117_CR37","doi-asserted-by":"crossref","first-page":"253","DOI":"10.3233\/JAD-2012-110935","volume":"30","author":"LJ Whalley","year":"2012","unstructured":"Whalley LJ, Sharma S, Fox HC, Murray AD, Staff RT, Duthie AC, et al. Anticholinergic drugs in late life: adverse effects on cognition but not on progress to dementia. J Alzheimers Dis. 2012;30:253\u201361.","journal-title":"J Alzheimers Dis"},{"key":"1117_CR38","doi-asserted-by":"crossref","first-page":"311","DOI":"10.2217\/1745509X.4.3.311","volume":"4","author":"M Boustani","year":"2008","unstructured":"Boustani M, Campbell N, Munger S, Maidment I, Fox C. Impact of anticholinergics on the aging brain: a review and practical application. Aging Health. 2008;4:311\u201320.","journal-title":"Aging Health"},{"key":"1117_CR39","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1097\/JCP.0b013e3182487825","volume":"32","author":"D Gnjidic","year":"2012","unstructured":"Gnjidic D, Le Couteur DG, Naganathan V, Cumming RG, Creasey H, Waite LM, et al. Effects of drug burden index on cognitive function in older men. J Clin Psychopharmacol. 2012;32:273\u20137.","journal-title":"J Clin Psychopharmacol"},{"key":"1117_CR40","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1177\/2042098613500689","volume":"4","author":"CV Bostock","year":"2013","unstructured":"Bostock CV, Soiza RL, Mangoni AA. Associations between different measures of anticholinergic drug exposure and Barthel Index in older hospitalized patients. Therap Adv Drug Saf. 2013;4:235\u201345.","journal-title":"Therap Adv Drug Saf"},{"key":"1117_CR41","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1007\/s40266-019-00731-3","volume":"37","author":"MP Tan","year":"2019","unstructured":"Tan MP, Tan GJ, Mat S, Luben RN, Wareham NJ, Khaw KT, et al. Use of Medications with anticholinergic properties and the long-term risk of hospitalization for falls and fractures in the EPIC-Norfolk longitudinal cohort study. Drugs Aging. 2019;37:105\u201314.","journal-title":"Drugs Aging"},{"key":"1117_CR42","doi-asserted-by":"crossref","first-page":"e0151084","DOI":"10.1371\/journal.pone.0151084","volume":"11","author":"MS Salahudeen","year":"2016","unstructured":"Salahudeen MS, Chyou TY, Nishtala PS. Serum anticholinergic activity and cognitive and functional adverse outcomes in older people: a systematic review and meta-analysis of the literature. PLoS ONE. 2016;11:e0151084.","journal-title":"PLoS ONE"},{"key":"1117_CR43","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.1001\/jama.2017.12126","volume":"318","author":"AC Alba","year":"2017","unstructured":"Alba AC, Agoritsas T, Walsh M, Hanna S, Iorio A, Devereaux PJ. Discrimination and calibration of clinical prediction models: users\u2019 guides to the medical literature. JAMA. 2017;318:1377\u201384.","journal-title":"JAMA"},{"key":"1117_CR44","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s00228-013-1575-8","volume":"70","author":"CP Kaufmann","year":"2014","unstructured":"Kaufmann CP, Tremp R, Hersberger KE, Lampert ML. Inappropriate prescribing: a systematic overview of published assessment tools. Eur J Clin Pharmacol. 2014;70:1\u201311.","journal-title":"Eur J Clin Pharmacol"}],"container-title":["International Journal of Clinical Pharmacy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11096-020-01117-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11096-020-01117-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11096-020-01117-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,8,28]],"date-time":"2021-08-28T23:40:46Z","timestamp":1630194046000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11096-020-01117-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,8,29]]},"references-count":44,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,2]]}},"alternative-id":["1117"],"URL":"https:\/\/doi.org\/10.1007\/s11096-020-01117-x","relation":{},"ISSN":["2210-7703","2210-7711"],"issn-type":[{"value":"2210-7703","type":"print"},{"value":"2210-7711","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,8,29]]},"assertion":[{"value":"7 April 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 July 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 August 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare that they have no conflict of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interest"}}]}}